Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Trials|May 5, 2021
Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical researchCiska Verbaanderd, Ilse Rooman, Isabelle HuysTrends in Cancer|August 8, 2017
Repurposing Drugs in Oncology: Next StepsCiska Verbaanderd, Lydie Meheus, Isabelle Huys, et al.Frontiers in Pharmacology|February 21, 2020
On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer PatientsCiska Verbaanderd, Ilse Rooman, Lydie Meheus, et al.Frontiers in Medicine|March 3, 2020
Sharing of Clinical Trial Data and Samples: The Cancer Patient PerspectiveStefanie Broes, Ciska Verbaanderd, Minne Casteels, et al.Seminars in Cancer Biology|January 27, 2020
Repurposing drugs in oncology: From candidate selection to clinical adoptionPan Pantziarka, Ciska Verbaanderd, Isabelle Huys, et al.Journal of Maxillofacial and Oral Surgery|October 19, 2016
Neuropathy of Trigeminal Nerve Branches After Oral and Maxillofacial TreatmentJimoh Olubanwo Agbaje, Elke Van de Casteele, Marjolein Hiel, et al.Ecancermedicalscience|December 12, 2017
Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agentsCiska Verbaanderd, Hannelore Maes, Marco B Schaaf, et al.Ecancermedicalscience|January 26, 2019
ReDO_DB: the repurposing drugs in oncology databasePan Pantziarka, Ciska Verbaanderd, Vidula Sukhatme, et al.Clinical Pharmacology and Therapeutics|May 3, 2023
Biomarker-Driven Developments in the Context of the New Regulatory Framework for Companion Diagnostics in the European UnionCiska Verbaanderd, Ana Trullás Jimeno, Jörg Engelbergs, et al.Frontiers in Medicine|December 27, 2021
Extension of Indication for Authorised Oncology Products in the European Union: A Joint Effort of Multiple StakeholdersJorn Mulder, Robin Verjans, Ciska Verbaanderd, et al.Pageof 2